摘要
美国药物治疗管理服务在解决和预防药物相关问题、提高药物治疗质量、降低医疗成本等方面发挥了重要作用。该文简要介绍美国医疗保险与美国老年和残障健康保险(Medicare)D部分药物治疗管理服务的受益人资格标准、服务提供者、服务要求、标准化文件等内容,以期为推动我国将药物治疗管理服务纳入医疗保险提供借鉴。
Medication therapy management(MTM)in the United States has played an important role in solving and preventing drug treatment-related problems,improving the quality of drug treatment,and reducing medical costs.This article briefly introduces MTM programs in medical insurance and Medicare Part D,including the beneficiary qualification standards,service providers,service requirements,and related standardized documents,in order to provide reference for MTM service into the medical insurance in China.
作者
宋维
葛佳佳
束庆
葛卫红
姚文兵
SONG Wei;GE Jiajia;SHU Qing;GE Weihong;YAO Wenbing(Nanjing Drum Tower Hospital of China Pharmaceutical University,Nanjing 210008,China;School of Basic Medicine and Clinical Pharmacy,China Pharmaceutical University,Nanjing 210009,China;National Development Research Center for Licensed Pharmacists,China Pharmaceutical University,Nanjing 210009,China)
出处
《医药导报》
CAS
北大核心
2021年第3期336-339,共4页
Herald of Medicine
关键词
药物治疗管理
美国
医疗保险
Medication therapy managements
United States
Medical insurance